CRISPR therapy corrects muscular dystrophy mutations and regrows muscles in mice

Researchers at the Experimental and Clinical Research Center (ECRC), a joint institution of the Max Delbrück Center and Charité—Universitätsmedizin Berlin, have developed a promising gene-editing approach intended to restore the function of a protein that is essential to repair and regrow muscle in patients with muscular dystrophy diseases. The findings are published in the journal Nature Communications.

Significantly shorter treatment regimens for tuberculosis in children and adults now recommended

Tuberculosis remains a public health crisis. The World Health Organization’s Global Tuberculosis Report released in November 2024 painted a sobering picture; approximately 8.2 million people were newly diagnosed with TB in 2023, the highest number since the organization began global TB monitoring in 1995. A major challenge in tuberculosis treatment has been the long duration needed to effectively treat the disease.

Optical imaging technique offers more precise diagnosis of sleep apnea

Obstructive sleep apnea (OSA) is a common sleep disorder characterized by intermittent airway blockages during sleep, leading to disrupted breathing. Despite advances in diagnostic tools, current methods for assessing the condition remain limited, often unable to provide a complete picture of the airway obstructions that occur during sleep. This has prompted the search for a more accurate, less invasive way to diagnose OSA and guide treatment decisions.